Fibrinogen, a natural soluble blood protein, is at the heart of Fibriant’s science, technology and products. The conversion of Fibrinogen, by active Thrombin, into the insoluble Fibrin matrix is a pivotal step in hemostasis, tissue repair and host-defense against infections. In nature Fibrinogen and Fibrin appear in different forms, each form with a specific and unique structure-function profile. This variation in form and function provides Fibriant with many opportunities to create new and improved, customized healthcare solutions based on specific variants of human Fibrinogen and Fibrin. Fibriant has developed a recombinant manufacturing platform to produce different variants of human Fibrinogen as well as active human Thrombin.
Location: Netherlands, South Holland, Leiden
Member count: 1-10
Investors 1
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 22.12.2021 | Largest-ev... | The European Commission has an... | Dutch Star... | Vishal Sin... | siliconcan... |